Transamerica Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.03M Buy
16,866
+2,297
+16% +$265K 0.17% 129
2025
Q4
$1.53M Buy
14,569
+462
+3% +$43.4K 0.13% 151
2025
Q3
$1.18M Buy
14,107
+10,829
+330% +$892K 0.1% 151
2025
Q2
$259K Buy
3,278
+1,646
+101% +$131K 0.02% 207
2025
Q1
$147K Sell
1,632
-24
-1% -$2.24K 0.02% 243
2024
Q4
$165K Buy
1,656
+1,556
+1,556% +$160K 0.02% 232
2024
Q3
$12K Sell
100
-6,855
-99% -$814K ﹤0.01% 331
2024
Q2
$861K Hold
6,955
0.09% 147
2024
Q1
$918K Sell
6,955
-12,306
-64% -$1.52M 0.09% 160
2023
Q4
$2.1M Sell
19,261
-5,751
-23% -$597K 0.29% 51
2023
Q3
$2.58M Sell
25,012
-1,934
-7% -$208K 0.35% 46
2023
Q2
$3.11M Sell
26,946
-210
-0.8% -$23.8K 0.4% 45
2023
Q1
$2.89M Sell
27,156
-2,844
-9% -$307K 0.38% 46
2022
Q4
$3.33M Buy
30,000
+2,200
+8% +$225K 0.47% 41
2022
Q3
$2.4M Buy
27,800
+1,102
+4% +$98.4K 0.35% 43
2022
Q2
$2.44M Buy
+26,698
New +$2.37M 0.34% 41
2021
Q3
Sell
-10
Closed -$1K 173
2021
Q2
$1K Sell
10
-16
-62% -$1.19K 0.02% 158
2021
Q1
$2K Sell
26
-5
-16% -$369 0.05% 102
2020
Q4
$3K Buy
31
+6
+24% +$459 0.06% 60
2020
Q3
$2K Sell
25
-3,263
-99% -$256K 0.04% 109
2020
Q2
$243K Buy
3,288
+3,274
+23,386% +$246K 0.05% 147
2020
Q1
$1K Hold
14
0.02% 106
2019
Q4
$2K Hold
14
0.03% 78
2019
Q3
$2K Sell
14
-2,195
-99% -$176K 0.03% 77
2019
Q2
$177K Buy
2,209
+2,196
+16,892% +$168K 0.04% 177
2019
Q1
$1K Sell
13
-1,342
-99% -$100K 0.01% 91
2018
Q4
$99K Buy
1,355
+516
+62% +$36.4K 0.03% 179
2018
Q3
$57K Buy
839
+781
+1,347% +$49.8K 0.01% 226
2018
Q2
$4K Sell
58
-20,536
-100% -$1.16M ﹤0.01% 284
2018
Q1
$1.07M Sell
20,594
-1,001
-5% -$54.1K 0.16% 136
2017
Q4
$1.16M Buy
21,595
+6,826
+46% +$378K 0.15% 143
2017
Q3
$903K Sell
14,769
-326
-2% -$19.8K 0.11% 149
2017
Q2
$924K Sell
15,095
-108
-0.7% -$6.57K 0.13% 134
2017
Q1
$922K Sell
15,203
-55
-0.4% -$3.34K 0.11% 155
2016
Q4
$858K Sell
15,258
-91
-0.6% -$5.33K 0.1% 150
2016
Q3
$915K Buy
15,349
+1,133
+8% +$66.3K 0.1% 158
2016
Q2
$782K Sell
14,216
-43,100
-75% -$2.29M 0.08% 167
2016
Q1
$2.89M Buy
57,316
+4,348
+8% +$213K 0.24% 91
2015
Q4
$2.67M Buy
52,968
+2,935
+6% +$148K 0.2% 98
2015
Q3
$2.36M Sell
50,033
-28,282
-36% -$1.5M 0.19% 97
2015
Q2
$4.25M Buy
78,315
+6,046
+8% +$339K 0.3% 62
2015
Q1
$3.96M Buy
72,269
+7,175
+11% +$406K 0.28% 54
2014
Q4
$3.53M Sell
65,094
-2,006
-3% -$112K 0.28% 47
2014
Q3
$3.8M Buy
67,100
+1,443
+2% +$81K 0.34% 42
2014
Q2
$3.63M Buy
65,657
+5,161
+9% +$282K 0.32% 50
2014
Q1
$3.28M Buy
60,496
+2,691
+5% +$139K 0.33% 41
2013
Q4
$2.76M Buy
57,805
+19,767
+52% +$904K 0.3% 46
2013
Q3
$1.73M Buy
38,038
+36,749
+2,851% +$1.68M 0.22% 55
2013
Q2
$58K Buy
+1,289
New +$57.6K 0.01% 263

Other funds holding MRK

Transamerica Financial Advisors's MRK Position: Q1 2026 in Review

Transamerica Financial Advisors increased its Merck (MRK) stake by 16% in Q1 2026, buying an estimated $265K and bringing the position to 16,866 shares worth $2.03M. The position accounts for 0.17% of the portfolio, ranked #129.

Transamerica Financial Advisors first reported a position in MRK in Q2 2013 and has held it in 49 quarters since. The position peaked at $4.25M in Q2 2015. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Transamerica Financial Advisors held 16,866 shares of Merck worth $2.03M as of Q1 2026.
  • Transamerica Financial Advisors bought 2,297 Merck shares in Q1 2026, an estimated $265K.
  • Merck made up 0.17% of Transamerica Financial Advisors's portfolio in Q1 2026, its #129 holding.
  • Transamerica Financial Advisors first reported a position in Merck in Q2 2013 and has held it in 49 quarters since.
  • Transamerica Financial Advisors's Merck position peaked at $4.25M in Q2 2015.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Transamerica Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.